Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
International Journal of Obesity
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
February 1998, Volume 22, Number 2, Pages 190-192
Table of contents    Previous  Abstract  Next   Article  PDF
Paper
Intermittent vs continuous VLCD therapy in obesity treatment
S Rössnera

Obesity Unit, Huddinge University Hospital, Huddinge, Sweden

aCorrespondence: Stephan Rössner, Obesity Unit, Huddinge Hospital, S 141 86 Huddinge, Sweden.

fax: 46 8 774 9962, e-mail: stephan.rossner@medhs.ki.se

Abstract

The role of intermittent very low calorie diet (VLCD) in obesity treatment has received little attention. Since such programs can be carried out with limited medical resources, they may offer an additional therapeutic tool. In two studies the effects of 420 or 530 kcal of Nutrilett Ò given daily to 40 and 61 patients [body mass index (BMI) 39.2±5.1 kg/m2 and 39.0±5.0 kg/m2, respectively], either continuously for six weeks or for three periods of two weeks with four weeks maintenance interval, were compared. Attrition and weight loss was similar in both groups after 14 and 26 weeks. Intermittent VLCD treatment seems to result in long term weight losses and compliance similar to those obtained by more continuous VLCD therapy. For some individuals less side effects would favour intermittent treatment, for others motivational factors support a more continuous VLCD treatment regimen.

Keywords

compliance; intermittent therapy; obesity; very low calorie diet

Received 15 April 1997; revised 8 September 1997; accepted 9 October 1997
February 1998, Volume 22, Number 2, Pages 190-192
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1998 Nature Publishing Group